Zobrazit v EDS

Incidence, survival and mortality rates of stage-specific bladder cancer in United States: A trend analysis

Uloženo v:
Podrobná bibliografie
Název: Incidence, survival and mortality rates of stage-specific bladder cancer in United States: A trend analysis
Autoři: Paul Perrotte, Niccolo Passoni, Jan Schmitges, Claudio Jeldres, Giorgio Gandaglia, Firas Abdollah, Rodolphe Thuret, Pierre I. Karakiewicz, Maxine Sun, Francesco Montorsi, Alberto Briganti, Shahrokh F. Shariat, Zhe Tian
Zdroj: Cancer Epidemiology. 37:219-225
Informace o vydavateli: Elsevier BV, 2013.
Rok vydání: 2013
Témata: Aged, 80 and over, Male, Incidence, Age Factors, United States, 3. Good health, Survival Rate, 03 medical and health sciences, 0302 clinical medicine, Urinary Bladder Neoplasms, Neoplasm staging, SEER program/statistics & numerical data, Survival analysis, Urinary bladder neoplasms/mortality, Aged, Female, Humans, Neoplasm Staging, SEER Program, Epidemiology, Oncology, Cancer Research
Popis: To examine the overall and stage-specific age-adjusted incidence, 5-year survival and mortality rates of bladder cancer (BCa) in the United States, between 1973 and 2009.A total of 148,315 BCa patients were identified in the Surveillance, Epidemiology and End Results database, between years 1973 and 2009. Incidence, mortality, and 5-year cancer-specific survival rates were calculated. Temporal trends were quantified using the estimated annual percentage change (EAPC) and linear regression models. All analyses were stratified according to disease stage, and further examined according to sex, race, and age groups.Incidence rate of BCa increased from 21.0 to 25.5/100,000 person-years between 1973 and 2009. Stage-specific analyses revealed an increase incidence for localized stage: 15.4-20.2 (EAPC: +0.5%, p < 0.001) and distant stage: 0.5-0.8 (EAPC: +0.7%, p = 0.001). Stage-specific 5-year survival rates increased for all stages, except for distant disease. No significant changes in mortality were recorded among localized (EAPC: -0.2%, p = 0.1) and regional stage (EAPC: -0.1%, p = 0.5). An increase in mortality rates was observed among distant stage (EAPC: +1.0%, p = 0.005). Significant variations in incidence and mortality were recorded when estimates were stratified according to sex, race, and age groups.Albeit statistically significant, virtually all changes in incidence and mortality were minor, and hardly of any clinical importance. Little or no change in BCa cancer control outcomes has been achieved during the study period.
Druh dokumentu: Article
Jazyk: English
ISSN: 1877-7821
DOI: 10.1016/j.canep.2013.02.002
Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/23485480
https://www.ncbi.nlm.nih.gov/pubmed/23485480
http://www.sciencedirect.com/science/article/pii/S1877782113000234
https://www.sciencedirect.com/science/article/pii/S1877782113000234
http://www.cancerepidemiology.net/article/S1877-7821(13)00023-4/fulltext
https://pubmed.ncbi.nlm.nih.gov/23485480/
https://europepmc.org/article/MED/23485480
Rights: Elsevier TDM
Přístupové číslo: edsair.doi.dedup.....f3f72169d7c07c26ebf266ea9c9f0711
Databáze: OpenAIRE
Popis
Abstrakt:To examine the overall and stage-specific age-adjusted incidence, 5-year survival and mortality rates of bladder cancer (BCa) in the United States, between 1973 and 2009.A total of 148,315 BCa patients were identified in the Surveillance, Epidemiology and End Results database, between years 1973 and 2009. Incidence, mortality, and 5-year cancer-specific survival rates were calculated. Temporal trends were quantified using the estimated annual percentage change (EAPC) and linear regression models. All analyses were stratified according to disease stage, and further examined according to sex, race, and age groups.Incidence rate of BCa increased from 21.0 to 25.5/100,000 person-years between 1973 and 2009. Stage-specific analyses revealed an increase incidence for localized stage: 15.4-20.2 (EAPC: +0.5%, p < 0.001) and distant stage: 0.5-0.8 (EAPC: +0.7%, p = 0.001). Stage-specific 5-year survival rates increased for all stages, except for distant disease. No significant changes in mortality were recorded among localized (EAPC: -0.2%, p = 0.1) and regional stage (EAPC: -0.1%, p = 0.5). An increase in mortality rates was observed among distant stage (EAPC: +1.0%, p = 0.005). Significant variations in incidence and mortality were recorded when estimates were stratified according to sex, race, and age groups.Albeit statistically significant, virtually all changes in incidence and mortality were minor, and hardly of any clinical importance. Little or no change in BCa cancer control outcomes has been achieved during the study period.
ISSN:18777821
DOI:10.1016/j.canep.2013.02.002